Analysis Nanobiotix S.A. (NBTX)
6/4/2024
Analysis of Nanobiotix S.A. (NBTX)
Nanobiotix S.A. (NBTX) has been showing some fluctuations in its stock price recently. The Relative Strength Index (RSI) values have been hovering around the mid-range, indicating a balanced market sentiment. The Moving Average Convergence Divergence (MACD) indicator has been fluctuating around the zero line, suggesting a lack of clear trend direction.The stock price has been moving within a range, with some volatility in the short term. The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been close to each other, indicating a stable trend. The Weighted Moving Average (WMA) has also been showing a similar pattern.
Overall, Nanobiotix S.A. seems to be experiencing a period of consolidation and uncertainty in the stock price movement. Traders and investors may need to closely monitor the price action and key technical indicators for potential trend reversals or breakouts in the near future.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been increasing, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally been increasing, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations over the years.
7. There is a fluctuating trend in current assets, possibly indicating varying short-term financial strategies.
8. The company has been managing its liabilities and equity effectively to support its asset base growth.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 31, 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the short ratio is low, and a significant portion of shares is held by institutions. The stock has a beta of 1.264 and has experienced a moderate change in its fifty-two week range.
Valuation metrics show a relatively high PEG ratio and forward P/E ratio. The company's market capitalization and enterprise value are substantial, with a high price-to-book ratio and price-to-sales ratio. The enterprise value to EBITDA and revenue ratios are also notable.
The stock price summary includes moving averages, fifty-two week high and low prices, and beta value.
Lastly, dividends and splits information shows the company's dividend dates, payout ratios, and dividend yields. The company has a history of dividends and stock splits, with both forward and trailing dividend rates and yields provided.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been fluctuating, with the highest in 2020 at $104.9 billion and the lowest in 2021 at $152.8 billion.
3. Operating income has also varied, with the highest in 2020 at $66.3 billion and the lowest in 2023 at $114.3 billion.
4. Net income has shown an increasing trend, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have been relatively stable, with slight fluctuations over the years.
6. The company has been able to maintain a consistent number of outstanding shares over the years.
7. Overall, the financial performance of the company in terms of revenue and profitability has shown positive growth trends over the years.
Cash Flow 💶
Based on the cash flow data provided, we can draw the following conclusions:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 at $111,443,000,000 and the lowest in 2020 at $73,365,000,000.
2. The operating cash flow has generally been increasing over the years, indicating improved operational efficiency and profitability.
3. The financing activities show significant variations, with large amounts being spent on common stock repurchase and dividends, as well as debt issuance and payments.
4. Investing activities also vary, with notable amounts being spent on the sale and purchase of investments, as well as capital expenditures.
5. The end cash position has been fluctuating, reaching its highest value in 2021 at $35,929,000,000 and its lowest in 2020 at $39,789,000,000.
6. Interest paid and income tax paid have also shown fluctuations over the years, reflecting changes in the company's financial obligations.
Overall, the company's cash flow statements indicate dynamic financial activities and performance over the years, with various factors influencing its cash position and operational efficiency.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates has increased to 38.
In the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term, with an increasing number of analysts providing forecasts.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. However, the company is still projected to experience healthy growth in the upcoming periods.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the median at $201.43. The current price of the security is $192.25, which is below both the average and median forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
MACD of NBTX
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
